Supramolecular Hydrogel Based Post-Surgical Implant System for Hydrophobic Drug Delivery Against Glioma Recurrence

References

• Tamargo RJ, Myseros JS, Epstein JI, Yang MB, Chasin M, Brem H. Interstitial Chemotherapy of the 9L Gliosarcoma: controlled Release Polymers for Drug Delivery in the Brain. Cancer Res. 1993;1:45.
   Google Scholar
• Nagpal S. The Role of BCNU Polymer Wafers (Gliadel) in the Treatment of Malignant Glioma. Neurosurg Clin. 2012;23(2):289–295. doi:10.1016/J.NEC.2012.01.004
   PubMed Web of Science ®Google Scholar
• Choucair AK, Levin VA, Gutin PH, et al. Development of multiple lesions during radiation therapy and chemotherapy in patients with gliomas. J Neurosurg. 1986;65(5):654–658. doi:10.3171/JNS.1986.65.5.0654
   PubMed Web of Science ®Google Scholar
• Loeffler J, Alexander E, Hochberg FH, et al. Clinical patterns of failure following stereotactic interstitial irradiation for malignant gliomas. Int J Radiat Oncol Biol Phys. 1990;(1):758. doi:10.1016/0360-3016(90)90358-Q
   Web of Science ®Google Scholar
• Brem H, Piantadosi S, Burger PC, et al. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Lancet. 1995;345(8956):1008–1012. doi:10.1016/S0140-6736(95)90755-6
   PubMed Web of Science ®Google Scholar
• Walter KA, Cahan MA, Gur A, et al. Interstitial Taxol Delivered from a Biodegradable Polymer Implant against Experimental Malignant Glioma1. Cancer Res. 1994;1:53.
   Google Scholar
• Storm PB, Moriarity JL, Tyler B, Burger PC, Brem H, Weingart J. Polymer delivery of camptothecin against 9L gliosarcoma: release, distribution, and efficacy. J Neurooncol. 2002;2:43. doi:10.1023/A:1015003232713
   Web of Science ®Google Scholar
• Vellimana AK, Recinos VR, Hwang L, et al. Combination of paclitaxel thermal gel depot with temozolomide and radiotherapy significantly prolongs survival in an experimental rodent glioma model. J Neurooncol. 2013;2:5443. doi:10.1007/s11060-012-1014-1
   Web of Science ®Google Scholar
• Su YW, Chang MC, Chiang MF, Hsieh RK. Treatment-related myelodysplastic syndrome after temozolomide for recurrent high-grade glioma. J Neuro-Oncology. 2005;71(3):315–318. doi:10.1007/S11060-004-2028-0
   PubMed Web of Science ®Google Scholar
• Natelson EA, Pyatt D. Temozolomide-induced myelodysplasia. Adv Hematol. 2010;2010:45. doi:10.1155/2010/760402
   Google Scholar
• Asyikin Binti Abdul Aziz Z, Ahmad A, Hamidah Mohd-Setapar S, et al. Recent Advances in Drug Delivery of Polymeric Nano-Micelles. Current Drug Metabo. 2017;18(1):16
   PubMed Web of Science ®Google Scholar
• Tseng YY, Chen TY, Liu SJ. Role of Polymeric Local Drug Delivery in Multimodal Treatment of Malignant Glioma: a Review. Int J Nanomedicine. 2021;16:4597. doi:10.2147/IJN.S309937
   PubMed Web of Science ®Google Scholar
• Grossen P, Witzigmann D, Sieber S, Huwyler J. PEG-PCL-based nanomedicines: a biodegradable drug delivery system and its application. J Control Release. 2017;260:46–60. doi:10.1016/j.jconrel.2017.05.028
   PubMed Web of Science ®Google Scholar
• Mei JH, Ma LG, Qian ZY, et al. One-step preparation of poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) nanoparticles for plasmid DNA delivery. J Biomed Mater Res. 2008;86(4):979–986. doi:10.1002/jbm.a.31704
   Web of Science ®Google Scholar
• Wang P, Wang H, Ma K, et al. Novel cytokine-loaded PCL-PEG scaffold composites for spinal cord injury repair. RSC Adv. 2020;10(11):6306–6314. doi:10.1039/c9ra10385f
   PubMed Web of Science ®Google Scholar
• Khodaverdi E, Delroba K, Mohammadpour F, et al. In-vitro Release Evaluation of Growth Hormone from an Injectable In-Situ Forming Gel Using PCL-PEG-PCL Thermosensitive Triblock. Curr Drug Deliv. 2020;17(2):174–183. doi:10.2174/1567201817666200120120105
   PubMed Web of Science ®Google Scholar
• Singh S, Alrobaian MM, Molugulu N, Agrawal N, Numan A, Kesharwani P. Pyramid-Shaped PEG-PCL-PEG Polymeric-Based Model Systems for Site-Specific Drug Delivery of Vancomycin with Enhance Antibacterial Efficacy. ACS Omega. 2020;5(21):11935–11945. doi:10.1021/ACSOMEGA.9B04064
   PubMed Web of Science ®Google Scholar
• Ohgaki H, Kleihues P. The definition of primary and secondary glioblastoma. Clin Cancer Res. 2013;19(4):764–772. doi:10.1158/1078-0432.CCR-12-3002
   PubMed Web of Science ®Google Scholar
• Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016;131(6):803–820. doi:10.1007/s00401-016-1545-1
   PubMed Web of Science ®Google Scholar
• Tseng YY, Huang YC, Yang TC, et al. Concurrent Chemotherapy of Malignant Glioma in Rats by Using Multidrug-Loaded Biodegradable Nanofibrous Membranes. Sci Reports. 2016;6(1):1–10. doi:10.1038/srep30630
   PubMed Web of Science ®Google Scholar
• Smith SJ, Tyler BM, Gould T, et al. Overall Survival in Malignant Glioma Is Significantly Prolonged by Neurosurgical Delivery of Etoposide and Temozolomide from a Thermo-Responsive Biodegradable Paste. Clin Cancer Res. 2019;25(16):5094–5106. doi:10.1158/1078-0432.CCR-18-3850
   PubMed Web of Science ®Google Scholar
• Vasudevan SM, Ashwanikumar N, Kumar GSV. Peptide decorated glycolipid nanomicelles for drug delivery across the blood–brain barrier (BBB). Biomater Sci. 2019;7(10):4017–4021.
   PubMed Web of Science ®Google Scholar
• Anto RJ, Mukhopadhyay A, Denning K, Aggarwal BB. Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, Bid cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl. Carcinogenesis. 2002;23(1):143–150.
   PubMed Web of Science ®Google Scholar
• Zanotto-Filho A, Braganhol E, Edelweiss MI, et al. The curry spice curcumin selectively inhibits cancer cells growth in vitro and in preclinical model of glioblastoma. J Nutr Biochem. 2012;23(6):591–601.
   PubMed Web of Science ®Google Scholar
• Zhuang W, Long L, Zheng B, et al. Curcumin promotes differentiation of glioma-initiating cells by inducing autophagy. Cancer Sci. 2012;103(4):684–690.
   PubMed Web of Science ®Google Scholar
• Mortezaee K, Salehi E, Mirtavoos-mahyari H, et al. Mechanisms of apoptosis modulation by curcumin: implications for cancer therapy. J Cell Physiol. 2019;234(8):12537–12550. doi:10.1002/JCP.28122
   PubMed Web of Science ®Google Scholar
• Shabaninejad Z, Pourhanifeh MH, Movahedpour A, et al. Therapeutic potentials of curcumin in the treatment of glioblastoma. Eur J Med Chem. 2020;188:112040.
   PubMed Web of Science ®Google Scholar
• Orunoğlu M, Kaffashi A, Pehlivan SB, et al. Effects of curcumin-loaded PLGA nanoparticles on the RG2 rat glioma model. Mater Sci Eng C. 2017;78:32–38.
   PubMed Web of Science ®Google Scholar
• Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, Pedersen LG. A smooth particle mesh Ewald method. J Chem Phys. 1998;103(19):8577.
   Web of Science ®Google Scholar
• Abraham MJ, Murtola T, Schulz R, et al. GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 2015;1-2:19–25.
   Google Scholar
• Schüttelkopf AW, van Aalten DMF. PRODRG: a tool for high-throughput crystallography of protein–ligand complexes. Acta Cryst. 2004;D60:1355–1363.
   Web of Science ®Google Scholar
• Lee SM, Yang EJ, Choi SM, Kim SH, Baek MG, Jiang JH. Effects of bee venom on glutamate-induced toxicity in neuronal and glial cells. Evid Based Complement Alternat Med. 2012;2012:356.
   Web of Science ®Google Scholar
• He J, Wang XM, Spector M, Cui FZ. Scaffolds for central nervous system tissue engineering. Front Mater Sci. 2012;6(1):1–25.
   Web of Science ®Google Scholar
• Hou S, Xu Q, Tian W, et al. The repair of brain lesion by implantation of hyaluronic acid hydrogels modified with laminin. J Neurosci Methods. 2005;148(1):60–70.
   PubMed Web of Science ®Google Scholar
• Paylor R, Nguyen M, Crawley JN, Patrick J, Beaudet A, Orr-Urtreger A. α7 nicotinic receptor subunits are not necessary for hippocampal- dependent learning or sensorimotor gating: a behavioral characterization of Acra7-deficient mice. Learn Mem. 1998;5(4–5):302–316.
   PubMed Web of Science ®Google Scholar
• Zhao H, Feng H, Liu J, et al. Dual-functional guanosine-based hydrogel integrating localized delivery and anticancer activities for cancer therapy. Biomaterials. 2020;230:119598.
   PubMed Web of Science ®Google Scholar
• Rowland MJ, Parkins CC, McAbee JH, et al. An adherent tissue-inspired hydrogel delivery vehicle utilised in primary human glioma models. Biomaterials. 2018;179:199–208.
   PubMed Web of Science ®Google Scholar
• Lu C, Guo S, Zhang Y, Yin M. Synthesis and aggregation behavior of four types of different shaped PCL-PEG block copolymers. Polym Int. 2006;55(6):694–700.
   Web of Science ®Google Scholar
• Asadi N, Annabi N, Mostafavi E, et al. Synthesis, characterization and in vitro evaluation of magnetic nanoparticles modified with PCL–PEG–PCL for controlled delivery of 5FU. Artif Cells Nanomed Biotechnol. 2018;46:938–945.
   PubMed Web of Science ®Google Scholar
• Liu CB, Gong CY, Huang MJ, et al. Thermoreversible gel-sol behavior of biodegradable PCL-PEG-PCL triblock copolymer in aqueous solutions. J Biomed Mater Res B Appl Biomater. 2008;84(1):165–175.
   PubMed Web of Science ®Google Scholar
• Liao R, Pon J, Chungyoun M, Nance E. Enzymatic protection and biocompatibility screening of enzyme-loaded polymeric nanoparticles for neurotherapeutic applications. Biomaterials. 2020;257:120238.
   PubMed Web of Science ®Google Scholar
• Grebenik EA, Surin AM, Bardakova KN, et al. Chitosan-g-oligo(L,L-lactide) copolymer hydrogel for nervous tissue regeneration in glutamate excitotoxicity: in vitro feasibility evaluation. Biomed Mater. 2020;15(1):015011.
   PubMed Web of Science ®Google Scholar
• Fournier E, Passirani C, Montero-Menei CN, Benoit JP. Biocompatibility of implantable synthetic polymeric drug carriers: focus on brain biocompatibility. Biomaterials. 2003;24(19):3311–3331.
   PubMed Web of Science ®Google Scholar
• Kreuter J. Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev. 2001;47(1):65–81.
   PubMed Web of Science ®Google Scholar
• Fourniols T, Randolph LD, Staub A, et al. Temozolomide-loaded photopolymerizable PEG-DMA-based hydrogel for the treatment of glioblastoma. J Control Release. 2015;210:95–104.
   PubMed Web of Science ®Google Scholar
• Tang L, Eaton JW. Inflammatory responses to biomaterials. Am J Clin Pathol. 1995;103(4):466–471.
   PubMed Web of Science ®Google Scholar
• Gogada R, Amadori M, Zhang H, et al. Curcumin induces Apaf-1-dependent, p21-mediated caspase activation and apoptosis. Cell Cycle. 2011;10(23):4128.
   PubMed Web of Science ®Google Scholar
• Karmakar S, Banik NL, Patel SJ, Ray SK. Curcumin activated both receptor-mediated and mitochondria-mediated proteolytic pathways for apoptosis in human glioblastoma T98G cells. Neurosci Lett. 2006;407(1):53–58.
   PubMed Web of Science ®Google Scholar
• Chaitanya GV, Alexander JS, Babu PP. PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration. Cell Commun Signal. 2010;8:31.
   PubMed Web of Science ®Google Scholar
• Kast RE, Hill QA, Wion D, et al. Glioblastoma-synthesized G-CSF and GM-CSF contribute to growth and immunosuppression: potential therapeutic benefit from dapsone, fenofibrate, and ribavirin. Tumour Biol. 2017;39:5.
   Google Scholar
• Alkhaibary A, Alassiri AH, AlSufiani F, Alharbi MA. Ki-67 labeling index in glioblastoma; does it really matter? Hematol Oncol Stem Cell Ther. 2019;12(2):82–88.
   PubMedGoogle Scholar
• Nielsen LAG, Bangsø JA, Lindahl KH, et al. Evaluation of the proliferation marker Ki-67 in gliomas: interobserver variability and digital quantification. Diagn Pathol. 2018;13(1):38.
   PubMed Web of Science ®Google Scholar